The New York Times on Sunday examined the South African government's adoption of a national treatment strategy to prevent mother-to-child HIV transmission. The country's Department of Health announced in January that it will begin requiring the World Health Organization -recommended strategy, which includes zidovudine and nevirapine.
Although some HIV/AIDS advocates are "celebrating the government's new policy," they also have said that South Africa "should have put it into practice long ago," the Times reports. Sibani Mngadi, a department of health spokesperson, said that the government had to review data and consult various people at WHO after the agency issued its guidelines in 2006. "There were a number of issues to be debated," he said (Dugger, New York Times, 3/9).
In related news, Reuters/Washington Post on Friday examined a recent government report that found a lack of financial resources could undermine the sustainability of South Africa's national HIV/AIDS plan.
Read More
No comments:
Post a Comment